September 5, 2025Bioconjugate ChemistryOpen Access

Dual Stimuli-Responsive Gemcitabine-Conjugated Alginate-Chitosan Nanoparticles for Triple-Negative Breast Cancer Therapy: A Smart Approach

View Full Paper

Ask AI

Bookmark

Dual stimuli-responsive nanoparticles significantly enhance gemcitabine's therapeutic efficacy against triple-negative breast cancer.
In vitro studies revealed enhanced cytotoxicity and apoptosis induction in various breast cancer cell lines including MCF-7 and MDA-MB-231.
The nanoparticles exhibited significant tumor growth inhibition in 4T1-Luc tumor-bearing mice, demonstrating improved treatment outcomes.
This innovative approach provides a safer alternative to traditional gemcitabine therapy by minimizing systemic toxicity.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Development of nanocarriers improved drug delivery and reduced toxicity in triple-negative breast cancer, indicating a promising therapeutic strategy.

Cite This Study

Patel et al. (2025) studied this question.

synapsesocial.com/papers/68c239a3b210217d6477d194 https://doi.org/10.1021/acs.bioconjchem.5c00334

View Full Paper

Ask AI

Bookmark

Implication

Development of nanocarriers improved drug delivery and reduced toxicity in triple-negative breast cancer, indicating a promising therapeutic strategy.

Dual Stimuli-Responsive Gemcitabine-Conjugated Alginate-Chitosan Nanoparticles for Triple-Negative Breast Cancer Therapy: A Smart Approach

Key Points

Discussion

Implication

Cite This Study

Dual Stimuli-Responsive Gemcitabine-Conjugated Alginate-Chitosan Nanoparticles for Triple-Negative Breast Cancer Therapy: A Smart Approach

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider